LSV Asset Management boosted its position in shares of Amdocs Ltd. (NASDAQ:DOX) by 1.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,582,300 shares of the company’s stock after buying an additional 17,500 shares during the period. LSV Asset Management owned 1.07% of Amdocs worth $91,536,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in DOX. Capital Fund Management S.A. raised its stake in Amdocs by 139.8% in the second quarter. Capital Fund Management S.A. now owns 211,494 shares of the company’s stock worth $12,207,000 after buying an additional 123,308 shares during the last quarter. PGGM Investments raised its stake in Amdocs by 3.6% in the second quarter. PGGM Investments now owns 743,332 shares of the company’s stock worth $42,905,000 after buying an additional 25,653 shares during the last quarter. BNP Paribas Arbitrage SA raised its stake in Amdocs by 0.6% in the second quarter. BNP Paribas Arbitrage SA now owns 29,796 shares of the company’s stock worth $1,720,000 after buying an additional 184 shares during the last quarter. Noesis Capital Mangement Corp raised its stake in Amdocs by 0.3% in the second quarter. Noesis Capital Mangement Corp now owns 131,315 shares of the company’s stock worth $7,580,000 after buying an additional 415 shares during the last quarter. Finally, Calvert Investment Management Inc. raised its stake in Amdocs by 3.9% in the second quarter. Calvert Investment Management Inc. now owns 8,304 shares of the company’s stock worth $479,000 after buying an additional 315 shares during the last quarter. Institutional investors and hedge funds own 88.68% of the company’s stock.

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Amdocs Ltd. (NASDAQ:DOX) opened at 60.48 on Tuesday. The firm has a market capitalization of $8.91 billion, a price-to-earnings ratio of 22.32 and a beta of 0.68. Amdocs Ltd. has a 52-week low of $50.06 and a 52-week high of $61.33. The company’s 50-day moving average price is $58.83 and its 200 day moving average price is $58.39.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Tuesday, November 8th. The company reported $0.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.00. The firm earned $940.70 million during the quarter, compared to the consensus estimate of $941.19 million. Amdocs had a return on equity of 14.61% and a net margin of 11.01%. The business’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.84 EPS. Equities research analysts predict that Amdocs Ltd. will post $3.79 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 13th. Investors of record on Friday, December 30th will be paid a $0.195 dividend. This represents a $0.78 annualized dividend and a yield of 1.29%. Amdocs’s dividend payout ratio is currently 28.78%.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this piece on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece can be read at https://www.thecerbatgem.com/2016/11/29/amdocs-ltd-dox-shares-bought-by-lsv-asset-management.html.

A number of equities analysts have recently commented on the company. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $65.00 price objective on shares of Amdocs in a report on Monday, August 8th. Jefferies Group raised their price objective on Amdocs from $56.00 to $58.00 and gave the stock a “hold” rating in a report on Tuesday, August 2nd. Finally, Bank of America Corp. restated a “buy” rating and issued a $63.00 price objective on shares of Amdocs in a report on Wednesday, November 9th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $63.33.

About Amdocs

Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.

5 Day Chart for NASDAQ:DOX

Receive News & Stock Ratings for Amdocs Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Ltd. and related stocks with our FREE daily email newsletter.